• 151. Back to Basics - Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer

  • Mar 29 2025
  • Length: 18 mins
  • Podcast

151. Back to Basics - Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer

  • Summary

  • The rise and rise of Androgen Receptor Pathway (or Signalling) Inhibitors has changed the world of metastatic prostate cancer forever. What was once a cancer with a finite number of treatment options has flourished into a chasm of therapies, many more effective and less toxic than their therapeutic grandparents.


    Studies discussed in the episode:

    ARCHES

    ENZAMET


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.



    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less

What listeners say about 151. Back to Basics - Androgen Receptor Pathway Inhibitors in Metastatic Prostate Cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.